ArticleNature2022
Omicron infection enhances Delta antibody immunity in vaccinated persons.
Open access · hybridAbstract read
In one paragraph
Article in Nature, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.
0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
8.4field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
53 citing papers in PubMed, 88 citations in OpenAlex.
- Host proteins associated with strong neutralizing SARS-CoV-2 antibody responses in a South African cohort.Communications medicine · 2026Article
- Impact of First SARS-CoV-2 Infection Variant on Serological Responses Against Omicron: Findings From the SIREN Study.Influenza and other respiratory viruses · 2026Article
- Evolution and viral properties of the SARS-CoV-2 BA.3.2 subvariant.Virus evolution · 2026Article
- Profiling of SARS-CoV-2 virus shedding, antibody neutralization, and T-cell receptor repertoires in a large, multi-center cohort of young adults with varied prior exposures.Frontiers in immunology · 2026Article
- Combining antigenic data from public sources gives an early indication of the immune escape of emerging virus variants.Scientific reports · 2025Article
- The consequences of SARS-CoV-2 within-host persistence.Nature reviews. Microbiology · 2025Review
- The Impact of Vaccination Frequency on COVID-19 Public Health Outcomes: A Model-Based Analysis.Vaccines · 2025Article
- Reflective Evaluation of Next-Generation Sequencing Data during Early Phase Detection of the Delta Variant.OBM genetics · 2025Article
- Vaccination against rapidly evolving pathogens and the entanglements of memory.Nature immunology · 2024Review
- Maternal Preconception COVID-19 Vaccination and Its Protective Effect on Infants after a Breakthrough Infection during Pregnancy.Vaccines · 2024Article
- Durability of immune responses to SARS-CoV-2 infection and vaccination.Seminars in immunology · 2024Review
- SARS-CoV-2 Neutralizing Antibodies in Three African Countries Following Multiple Distinct Immune Challenges.Vaccines · 2024Article
- Clearance of persistent SARS-CoV-2 associates with increased neutralizing antibodies in advanced HIV disease post-ART initiation.Nature communications · 2024Article
- Comparison of Neutralizing Activity between Vaccinated and Unvaccinated Hospitalized COVID-19 Patients Infected with Delta, Omicron BA.1, or Omicron BA.2 Variant.Microorganisms · 2024Article
- Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.PLOS global public health · 2024Article
- Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants.NPJ vaccines · 2023Article
- Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection.Nature immunology · 2023Article
- A Meta-Analysis on the Association between Peptic Ulcer Disease and COVID-19 Severity.Vaccines · 2023Review
- Immunological imprinting: Understanding COVID-19.Immunity · 2023Review
- Long COVID and Hybrid Immunity among Children and Adolescents Post-Delta Variant Infection in Thailand.Vaccines · 2023Article
Corrections and comments
- Update of
Authors and funding
40 authors at 12 institutions in 6 countries.
Khadija Khan *Africa Health Research Institute, Durban, South Africa.ORCID http://orcid.org/0000-0001-7565-7400
Farina Karim *Africa Health Research Institute, Durban, South Africa.
Sandile CeleAfrica Health Research Institute, Durban, South Africa.
Kajal ReedoyAfrica Health Research Institute, Durban, South Africa.
James Emmanuel SanKwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa.ORCID http://orcid.org/0000-0002-5736-664X
Gila LustigCentre for the AIDS Programme of Research in South Africa, Durban, South Africa.
Houriiyah TegallyKwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa.
Yuval RosenbergDepartment of Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0002-6681-8329
Mallory BernsteinAfrica Health Research Institute, Durban, South Africa.
Zesuliwe JuleAfrica Health Research Institute, Durban, South Africa.
Yashica GangaAfrica Health Research Institute, Durban, South Africa.
Nokuthula NgcoboAfrica Health Research Institute, Durban, South Africa.
Matilda MazibukoAfrica Health Research Institute, Durban, South Africa.
Ntombifuthi MthabelaAfrica Health Research Institute, Durban, South Africa.
Zoey MhlaneAfrica Health Research Institute, Durban, South Africa.
Nikiwe MbathaAfrica Health Research Institute, Durban, South Africa.
Yoliswa MiyaAfrica Health Research Institute, Durban, South Africa.
Jennifer GiandhariKwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa.
Yajna RamphalKwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa.
Taryn NaidooAfrica Health Research Institute, Durban, South Africa.
Aida SivroCentre for the AIDS Programme of Research in South Africa, Durban, South Africa.
Natasha SamsunderCentre for the AIDS Programme of Research in South Africa, Durban, South Africa.
Ayesha B M KharsanyCentre for the AIDS Programme of Research in South Africa, Durban, South Africa.
Daniel AmoakoNational Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
Jinal N BhimanNational Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.
Nithendra ManickchundDepartment of Infectious Diseases, Nelson R. Mandela School of Clinical Medicine, University of KwaZulu-Natal, Durban, South Africa.
Quarraisha Abdool KarimCentre for the AIDS Programme of Research in South Africa, Durban, South Africa.
Nombulelo MagulaDepartment of Internal Medicine, Nelson R. Mandela School of Medicine, University of Kwa-Zulu Natal, Durban, South Africa.
Salim S Abdool KarimCentre for the AIDS Programme of Research in South Africa, Durban, South Africa.
Glenda GraySouth African Medical Research Council, Cape Town, South Africa.
Willem HanekomAfrica Health Research Institute, Durban, South Africa.
Anne von GottbergNational Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.ORCID http://orcid.org/0000-0002-0243-7455
COMMIT-KZN Team
Ron MiloDepartment of Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot, Israel.ORCID http://orcid.org/0000-0003-1641-2299
Bernadett I GosnellDepartment of Infectious Diseases, Nelson R. Mandela School of Clinical Medicine, University of KwaZulu-Natal, Durban, South Africa.ORCID http://orcid.org/0000-0002-6336-7489
Richard J LessellsKwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa.ORCID http://orcid.org/0000-0003-0926-710X
Penny L MooreCentre for the AIDS Programme of Research in South Africa, Durban, South Africa.ORCID http://orcid.org/0000-0001-8719-4028
Tulio de OliveiraKwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa.
Mahomed-Yunus S MoosaDepartment of Infectious Diseases, Nelson R. Mandela School of Clinical Medicine, University of KwaZulu-Natal, Durban, South Africa.ORCID http://orcid.org/0000-0001-6191-4023
Alex SigalAfrica Health Research Institute, Durban, South Africa. alex.sigal@ahri.org.ORCID http://orcid.org/0000-0001-8571-2004
Africa Health Research Institute · ZACentre for the AIDS Programme of Research in South Africa · ZAUniversity of KwaZulu-Natal · ZANational Health Laboratory Service · ZAUniversity of Alabama at Birmingham · USSouth African Medical Research Council · ZAWeizmann Institute of Science · ILRagon Institute of MGH, MIT and Harvard · USSouth African Association for Marine Biological Research · ZAStellenbosch University · ZAUniversity of Copenhagen · DKUniversity of Washington · US
Funding
Identification of the HIV Reservoir in Lymph Nodes Using Single Cell RNA-SeqR01AI138546 · NIAID · KWAZULU-NATAL RESEARCH INSTITUTE TB-HIV · PI SIGAL, ALEXANDER · 2018 to 2022
$721kMedical Research CouncilNIAID NIH HHS R01 AI138546Wellcome TrustWellcome Trust 221003/Z/20/Z
Abstract
The extent to which Omicron infection
Indexed as
Antibodies, NeutralizingAntibodies, ViralCOVID-19COVID-19 VaccinesCross ProtectionSARS-CoV-2VaccinationAd26COVS1BNT162 VaccineHumansAd26COVS1Antibodies, NeutralizingAntibodies, ViralBNT162 VaccineCOVID-19 Vaccines
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.